The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Antiemesis, Version 2.2017
Open accessAbstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Olanzapine for the prevention of chemotherapy-induced nausea and vomiting.
Navari, R. M., Qin, R., Ruddy, K. J., Liu, H., Powell, S. F., Bajaj, M., Dietrich, L., Biggs, D., Lafky, J. M., & Loprinzi, C. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515725 · Cited by 452
Self-citationRichardson, J. L., Marks, G., & Levine, A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.11.1746 · Cited by 180
Cited by
Reconsidering Dexamethasone for Antiemesis when Combining Chemotherapy and Immunotherapy
Janowitz, T., Kleeman, S., & Vonderheide, R. H. (2021) · The Oncologist · doi:10.1002/onco.13680 · Cited by 42
“1): baseline (for example, patients with chronic autoimmune conditions), antiemetic prophylaxis for HEC, and secondary immune modulation in patients with immune-related adverse effects (irAEs), such as colitis [42]. irAEs are strongly associated with beneficial responses [43–46], likely reflecting systemic immune comp…”
MethodInfluentialHarder, S., Groenvold, M., Isaksen, J., Sigaard, J., Frandsen, K. B., Neergaard, M. A., Mondrup, L., & Herrstedt, J. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-018-4593-3 · Cited by 17
Metadata
- Authors
- Berger, M. J., Ettinger, D. S., Aston, J., Barbour, S., Bergsbaken, J., Bierman, P. J., Brandt, D., Dolan, D. E., Ellis, G., Kim, E. J., Kirkegaard, S., Kloth, D. D., Lagman, R., Lim, D., Loprinzi, C., Ma, C. X., Maurer, V., Michaud, L. B., Nabell, L. M., Noonan, K., Roeland, E., Rugo, H. S., Schwartzberg, L. S., Scullion, B., Timoney, J., Todaro, B., Urba, S. G., Shead, D. A., & Hughes, M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2017-07
- Volume
- 15
- Issue
- 7
- Pages
- 883-893
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2726372533
- Cited by
- 252
- References
- 2
- FWCI
- 22.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NCCN Guidelines Insights: Antiemesis, Version 2.2017. https://app.cochat.ai/papers/10.6004/jnccn.2017.0117
- The paper
- Berger, M. J., Ettinger, D. S., Aston, J., Barbour, S., Bergsbaken, J., Bierman, P. J., Brandt, D., Dolan, D. E., Ellis, G., Kim, E. J., Kirkegaard, S., Kloth, D. D., Lagman, R., Lim, D., Loprinzi, C., Ma, C. X., Maurer, V., Michaud, L. B., Nabell, L. M., . . . Hughes, M. (2017). NCCN Guidelines Insights: Antiemesis, Version 2.2017. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2017.0117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.